Fear is mounting globally over the coronavirus outbreak disease, and Africa is not left out. Ivory Coast health officials are dealing with what they call a suspected case of the virus.
The country’s health ministry has announced, an unnamed student has shown flu-like symptoms and is undergoing further tests. She returned to ivory coast from Beijing on Saturday. If confirmed, it will be the first case of the deadly virus in Africa.
The virus that first emerged in the Chinese city of Wuhan, has spread to more than 2,000 persons killing at least 80 as at Monday.
Officials say the 34-year-old woman is currently in isolation. Ivory Coast’s health ministry says she has lived in china for the past five years, and had shown flu-like symptoms before boarding the plane to Abidjan.
Since the outbreak began in Wuhan, several African countries have introduced extra screening on flights arriving from china.
Nigerian health authorities have begun conducting checks at Lagos airport.
Ethiopia, South Africa, Kenya, Ghana and Botswana are doing the same in their countries.
General: COVID-19 Vaccines Will Be Ready For Delivery 24 Hours After FDA Authorization
Four-Star general Gustave Perna who is leading the U.S. government’s operation warp speed, the crash program to develop, produce, and distribute enough COVID-19 vaccine doses to inoculate 300 million Americans, says he is confident vaccines will be “on the streets 24 hours after being authorized by the food and drug administration.
The operation is stockpiling anticipated vaccines made by six different drug makers.
While the first two vaccines to be distributed will likely be from Pfizer and Moderna, the U.S. Secretary of Health and Human Affairs, Alex Azar, described the news from Astra zeneca’s clinical trials as “very promising” and noted that the company’s vaccine is already being produced in the country so it too can be ready for distribution once authorized by the FDA.
Azar confirmed the drugmaker is already producing mass quantities of the vaccine in the U.S.
Last week, Pfizer applied for authorization from the FDA and a hearing date was set for mid-December.
Kenya Nurses Issue Strike Warning
Kenyan nurses have issued a 14-day strike action warning to the government. The medical workers sign the notice, citing lack of a safe working environment and protective gears- PPE`s. They are demanding that the government declare COVID-19 an occupational hazard. They are also asking to be provided with comprehensive medical cover.
The nurses’ union secretary general Seth Panyako alleged, eighteen nurses have died from COVID-19 after treating patients with the virus. He added that once the strike notice lapses, the healthcare workers will not return to work unless their issues are addressed.
The notice comes a week after doctors issued a strike notice over the same issues.
More than 78,500 COVID-19 cases have been confirmed in Kenya including 1,409 deaths being reported.
More than 30 healthcare workers are reported to have died after contracting the virus since the country confirmed its first case in March.
U.S. FDA Grants Emergency Authorization For COVID-19 Treatment From Regeneron
The U.S. Food and drug administration has granted emergency authorization for the Regeneron antibody treatment, the same drug that was administered to president Donald Trump after he was diagnosed with COVID-19.
The drug’s approval is limited in scope for people who have tested positive for the coronavirus and who are at high risk for developing severe COVID-19.
Regeneron says it will have enough of the drug for at least eighty thousand patients by the end of this month. It says, by the first week of January, it would have enough for 200,000 patients, and for 300,000 by the end of January.
The United States has surpassed the 12 million infection mark, and nearly two hundred seventy Americans have died from complications from the disease.